These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 9506739)
41. Regulation and actions of Smad7 in the modulation of activin, inhibin, and transforming growth factor-beta signaling in anterior pituitary cells. Bilezikjian LM; Corrigan AZ; Blount AL; Chen Y; Vale WW Endocrinology; 2001 Mar; 142(3):1065-72. PubMed ID: 11181520 [TBL] [Abstract][Full Text] [Related]
42. Dynamic regulation of pituitary follistatin messenger ribonucleic acids during the rat estrous cycle. Halvorson LM; Weiss J; Bauer-Dantoin AC; Jameson JL Endocrinology; 1994 Mar; 134(3):1247-53. PubMed ID: 8119165 [TBL] [Abstract][Full Text] [Related]
43. Follistatins and alpha 2-macroglobulin are soluble binding proteins for inhibin and activin. Mather JP Horm Res; 1996; 45(3-5):207-10. PubMed ID: 8964585 [TBL] [Abstract][Full Text] [Related]
44. Bovine follicle development is associated with divergent changes in activin-A, inhibin-A and follistatin and the relative abundance of different follistatin isoforms in follicular fluid. Glister C; Groome NP; Knight PG J Endocrinol; 2006 Feb; 188(2):215-25. PubMed ID: 16461548 [TBL] [Abstract][Full Text] [Related]
45. Amniotic fluid concentrations of dimeric inhibins, activin A and follistatin in pregnancy. Muttukrishna S; Chamberlain P; Evans LW; Asselin J; Groome NP; Ledger WL Eur J Endocrinol; 1999 May; 140(5):420-4. PubMed ID: 10229907 [TBL] [Abstract][Full Text] [Related]
46. Follistatin: essential role for the N-terminal domain in activin binding and neutralization. Sidis Y; Schneyer AL; Sluss PM; Johnson LN; Keutmann HT J Biol Chem; 2001 May; 276(21):17718-26. PubMed ID: 11279126 [TBL] [Abstract][Full Text] [Related]
47. Roles of inhibins, activins, and follistatin in the female reproductive system. Knight PG Front Neuroendocrinol; 1996 Oct; 17(4):476-509. PubMed ID: 8905350 [TBL] [Abstract][Full Text] [Related]
48. Activins, inhibins, and follistatins: from endocrinology to signaling. A paradigm for the new millennium. Welt C; Sidis Y; Keutmann H; Schneyer A Exp Biol Med (Maywood); 2002 Oct; 227(9):724-52. PubMed ID: 12324653 [TBL] [Abstract][Full Text] [Related]
49. Tissue-specific binding of radiolabeled activin A by activin receptors and follistatin in postimplantation rat and mouse embryos. Roberts VJ; Bentley CA; Guo Q; Matzuk MM; Woodruff TK Endocrinology; 1996 Oct; 137(10):4201-9. PubMed ID: 8828478 [TBL] [Abstract][Full Text] [Related]
50. Effects of growth hormone, activin, and follistatin on the development of preantral follicle from immature female mice. Liu X; Andoh K; Yokota H; Kobayashi J; Abe Y; Yamada K; Mizunuma H; Ibuki Y Endocrinology; 1998 May; 139(5):2342-7. PubMed ID: 9564843 [TBL] [Abstract][Full Text] [Related]
51. Serum activin A and follistatin concentrations during human pregnancy: a cross-sectional and longitudinal study. O'Connor AE; McFarlane JR; Hayward S; Yohkaichiya T; Groome NP; de Kretser DM Hum Reprod; 1999 Mar; 14(3):827-32. PubMed ID: 10221721 [TBL] [Abstract][Full Text] [Related]
52. The role of follistatin domains in follistatin biological action. Keutmann HT; Schneyer AL; Sidis Y Mol Endocrinol; 2004 Jan; 18(1):228-40. PubMed ID: 14563935 [TBL] [Abstract][Full Text] [Related]
53. Difference between follistatin isoforms in the inhibition of activin signalling: activin neutralizing activity of follistatin isoforms is dependent on their affinity for activin. Hashimoto O; Kawasaki N; Tsuchida K; Shimasaki S; Hayakawa T; Sugino H Cell Signal; 2000 Aug; 12(8):565-71. PubMed ID: 11027950 [TBL] [Abstract][Full Text] [Related]
54. Circulating levels of follistatin from puberty to menopause. Kettel LM; DePaolo LV; Morales AJ; Apter D; Ling N; Yen SS Fertil Steril; 1996 Mar; 65(3):472-6. PubMed ID: 8774272 [TBL] [Abstract][Full Text] [Related]
55. Inhibin, activin and follistatin bind preferentially to the transformed species of alpha 2-macroglobulin. Phillips DJ; McFarlane JR; Hearn MT; de Kretser DM J Endocrinol; 1997 Oct; 155(1):65-71. PubMed ID: 9390007 [TBL] [Abstract][Full Text] [Related]
56. Increased follistatin (activin-binding protein) gene expression in rat anterior pituitary tissue after ovariectomy may be mediated by pituitary activin. DePaolo LV; Mercado M; Guo Y; Ling N Endocrinology; 1993 May; 132(5):2221-8. PubMed ID: 8477666 [TBL] [Abstract][Full Text] [Related]
57. Activin and follistatin as local regulators in the human ovary. Peng C; Ohno T; Khorasheh S; Leung PC Biol Signals; 1996; 5(2):81-9. PubMed ID: 8836491 [TBL] [Abstract][Full Text] [Related]
58. Molecular heterogeneity of follistatin, an activin-binding protein. Higher affinity of the carboxyl-terminal truncated forms for heparan sulfate proteoglycans on the ovarian granulosa cell. Sugino K; Kurosawa N; Nakamura T; Takio K; Shimasaki S; Ling N; Titani K; Sugino H J Biol Chem; 1993 Jul; 268(21):15579-87. PubMed ID: 8340384 [TBL] [Abstract][Full Text] [Related]
59. Follistatin Forms a Stable Complex With Inhibin A That Does Not Interfere With Activin A Antagonism. Kappes EC; Kattamuri C; Czepnik M; Yarawsky AE; Brûlé E; Wang Y; Ongaro L; Herr AB; Walton KL; Bernard DJ; Thompson TB Endocrinology; 2023 Jan; 164(3):. PubMed ID: 36718082 [TBL] [Abstract][Full Text] [Related]
60. Serum inhibin, activin and follistatin in postmenopausal women with epithelial ovarian carcinoma. Menon U; Riley SC; Thomas J; Bose C; Dawnay A; Evans LW; Groome NP; Jacobs IJ BJOG; 2000 Sep; 107(9):1069-74. PubMed ID: 11002947 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]